Physician
Dermatology
Dr. Michael A. Trauner, MD
|
|
Give Review
Dr. Michael A. Trauner works in the field of Dermatology. He graduated from Duke University School of Medicine. Duke University School of Medicine is one of the top medical schools in the US. Duke University School of Medicine is ranked 8 in research and 29 in primary care medicine He over the years received 3 awards: "CMS Meaningful Use Stage 1 Certification", "Fellow (FAAD)" and "Fellow (FASDS)". Michael Trauner is a published physician as well. He has 98 publications published. The latest was: Nitric oxide and guanosine 3',5'-cyclic monophosphate stimulate bile secretion in isolated rat hepatocyte couplets, but not in isolated bile duct units. Dr. Michael A. Trauner accepts Medicare.
Publications
- Ubc9 impairs activation of the brown fat energy metabolism program in human white adipocytes.
- Efficacy of Obeticholic Acid in Patients with Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid.
- Lithocholic acid feeding results in direct hepato-toxicity independent of neutrophil function in mice.
- Osteopontin is an initial mediator of inflammation and liver injury during obstructive cholestasis after bile duct ligation in mice.
- Liver Transplantation: Impaired Biliary Excretion of Gadoxate Is Associated With an Inferior 1-Year Retransplantation-Free Survival.
- Segmental tuberous sclerosis presenting as unilateral facial angiofibromas.
- Groin eruption in an HIV-positive man: epidermodysplasia verruciformis (EDV).
- Endoscopic intracorporeal laser lithotripsy of difficult common bile duct stones with a stone-recognition pulsed dye laser system.
- Quantitative perfusion parameters of focal nodular hyperplasia and normal liver parenchyma as determined by electron beam tomography.
- Nitric oxide and liver disease.
- [Indications for liver transplantation in neoplasms of the liver].
- Lateral hypothalamic Lesions cause gastric injury by stimulating gastric contractility.
- Glomerulonephritis as late manifestation of severe alpha 1-antitrypsin deficiency.
- [Ultrasound controlled extracorporeal shockwave lithotripsy of pancreatic calculi in patients with chronic recurrent pancreatitis].
- Recurrent Salmonella enteritidis sepsis and hepatic tuberculosis.
- Evaluation of carbohydrate-deficient transferrin for detection of alcohol abuse in patients with liver dysfunction.
- Laparoscopic diagnosis of peritoneal serous papillary Carcinoma.
- Lack of pineal growth during childhood.
- Carcinoembryonic antigen, cytokeratin expression and mucin composition in hyperplastic and neoplastic polyps of the colorectum.
- Forearm muscles of man can reverse their function after tendon transfers: an electromyographic study.
- Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases.
- [New molecular aspects of cholestatic liver diseases].
- Molecular regulation of hepatoCellular transport systems in cholestasis.
- Nitric oxide and guanosine 3',5'-cyclic monophosphate stimulate bile secretion in isolated rat hepatocyte couplets, but not in isolated bile duct units.
- Molecular pathogenesis of cholestasis.
- Successful steroid treatment of idiopathic thrombocytopenic purpura after orthotopic liver transplantation for primary biliary cirrhosis.
- Neither intestinal sequestration of bile acids nor common bile duct ligation modulate the expression and function of the rat ileal bile acid transporter.
- Maternal cholestasis does not affect the ontogenic pattern of expression of the Na+/taurocholate cotransporting polypeptide (ntcp) in the fetal and neonatal rat liver.
- Vasopressin reverses mesenteric hyperemia and vasoconstrictor hyporesponsiveness in anesthetized portal hypertensive rats.
- Molecular alterations of canalicular transport systems in experimental models of cholestasis: possible functional correlations.
- Role of glutathione in hepatic bile formation during reperfusion after Cold ischemia of the rat liver.
- Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors.
- Extrahepatic biliary obstruction impairs microvascular perfusion and increases leukocyte adhesion in rat liver.
- Inhibition of nitric oxide synthesis in ischemia/reperfusion of the rat liver is followed by impairment of hepatic microvascular blood flow.
- The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis.
- Endotoxin impairs biliary glutathione and HCO3- excretion and blocks the choleretic effect of nitric oxide in rat liver.
- Nitric oxide donors stimulate bile flow and glutathione disulfide excretion independent of guanosine 3',5'-cyclic [corrected] monophosphate in the isolated perfused ra...
- ERCP and balloon dilation is a valuable alternative to surgical biliodigestive anastomosis in the long common channel syndrome in childhood.
- Complications and surgical interventions during 4 years of biliary extracorporeal shockwave lithotripsy.
- Divergent effects of propranolol and nadolol in isolated mesenteric arteries from normal and portal hypertensive rats.
- Sonographically-guided extracorporeal shockwave lithotripsy for pancreatic stones in patients with chronic pancreatitis.
- CRF microinjected into the dorsal vagal complex inhibits TRH analog- and kainic acid-stimulated gastric contractility in rats.
- Diagnostic problems in nodular regenerative hyperplasia (nodular transformation) of the liver. Review of the literature and report of two cases.
- Thyrotropin-releasing hormone analog injected into the raphe pallidus and obscurus increases gastric contractility in rats.
- Expression of the bile salt export pump is maintained after chronic cholestasis in the rat.
- Inflammation-induced cholestasis.
- Abnormal hepatic sinusoidal bile acid transport: new insights into the pathogenesis of cholestasis?
- Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases.
- HepatoCellular bile salt transport: lessons from cholestasis.
- Intra-hepatic haematoma complicating transjugular intra-hepatic portosystemic shunt for Budd-Chiari syndrome associated with anti-phospholipid antibodies, aplastic ana...
- No evidence for mutagenic effects of ribavirin: report of two normal pregnancies.
- Effects of ursodeoxycholic and cholic acid feeding on hepatoCellular transporter expression in mouse liver.
- Genetic disorders and molecular mechanisms in cholestatic liver disease--a clinical approach.
- Successful management of acute portal vein thrombosis by low molecular weight heparin and oral anticoagulation.
- [Diffuse hemangiomatosis of the liver and spleen in an adult].
- Extracorporeal albumin dialysis in a patient with primary sclerosing cholangitis: effect on pruritus and bile acid profile.
- Bile secretory function in the obese Zucker rat: evidence of cholestasis and altered canalicular transport function.
- Austrian consensus on the definition and treatment of portal hypertension and its complications.
- [Addison''s disease as a rare cause of chronically elevated liver enzymes].
- Cholestatic syndromes.
- The Genome Austria Tissue Bank (GATiB).
- [Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease. Grade 2 consensus-based guidelines].
- [Histopathological diagnose of non-alcoholic and alcoholic fatty liver disease].
- Curcumin improves sclerosing cholangitis in Mdr2-/- mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation.
- Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis.
- Cytokeratins as targets for bile acid-induced toxicity.
- Signal transducer and activator of transcription 3 protects from liver injury and fibrosis in a mouse model of sclerosing cholangitis.
- Disruption of the growth hormone--signal transducer and activator of transcription 5--insulinlike growth factor 1 axis severely aggravates liver fibrosis in a mouse mo...
- The new therapeutic frontier--nuclear receptors and the liver.
- Farnesoid X receptor critically determines the fibrotic response in mice but is expressed to a low extent in human hepatic stellate Cells and periductal myofibroblasts.
- The human UGT1A3 enzyme conjugates norursodeoxycholic acid into a C23-ester glucuronide in the liver.
- Fatty liver and lipotoxicity.
- Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment.
- Imbalance of pro- and antifibrogenic genes and bile duct injury in murine Schistosoma mansoni Infection-induced liver fibrosis.
- Evaluation of indocyanine green clearance and model for end-stage liver disease for estimation of short-term prognosis in decompensated cirrhosis.
- Serum gamma-glutamyl transferase and mortality in persons undergoing coronary angiography-The Ludwigshafen Risk and Cardiovascular Health Study.
- New molecular insights into the mechanisms of cholestasis.
- The role of the hepatocyte cytokeratin network in bile formation and resistance to bile acid challenge and cholestasis in mice.
- Impact of experimental colitis on hepatobiliary transporter expression and bile duct injury in mice.
- Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-/- mice.
- Nuclear receptor ligands in therapy of cholestatic liver disease.
- Hepatocyte nuclear factor-4alpha and bile acids regulate human concentrative nucleoside transporter-1 gene expression.
- When lightning strikes twice: the plot thickens for a dual role of the anion exchanger 2 (AE2/SLC4A2) in the pathogenesis and treatment of primary biliary cirrhosis.
- Nuclear receptors as therapeutic targets in cholestatic liver diseases.
- Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases.
- Nuclear bile acid receptor farnesoid X receptor meets nuclear factor-kappaB: new insights into hepatic inflammation.
- Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia.
- Validated comprehensive analytical method for quantification of coenzyme A activated compounds in biological tissues by online solid-phase extraction LC/MS/MS.
- Ischemia and cholestasis: more than (just) the bile ducts!
- Role of hepatic phospholipids in development of liver injury in Mdr2 (Abcb4) knockout mice.
- Mechanisms of cholestasis.
- Fatal hemobilia resulting from an iatrogenic arteriobiliary fistula as a rare complication of transjugular liver biopsy.
- Clinical hepatotoxicity. Regulation and treatment with inducers of transport and cofactors.
- Extrahepatic cholestasis downregulates Oatp1 by TNF-alpha signalling without affecting Oatp2 and Oatp4 expression and sodium-independent bile salt uptake in rat liver.
- Ursodeoxycholic Acid in patients with chronic heart failure a double-blind, randomized, placebo-controlled, crossover trial.
- Pathogenesis of primary sclerosing cholangitis.
- Hepatobiliary transporter expression and post-operative jaundice in patients undergoing partial hepatectomy.
Schools
Duke University
Kaiser Permanente Mc
University Calif Davis
New England Mc
Procedures Preformed
- Acne Surgery
- Adjacent Tissue Transfer
- Dermabrasion
- Destruction of Benign Skin Lesion
- View All
Conditions Treated
- Acanthosis Nigricans
- Acne
- Actinic Keratosis
- Athlete's Foot
- View All
Doctors Specialties
- Dermatology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FAAD)
- Fellow (FASDS)
Education
-
University of California Davis -
Kaiser Permanente Medical Center -
Duke University School of Medicine
Drug Facts
| NPI NUMBER | 1558460394 | |
| NPPES Provider LastName | TRAUNER | |
| NPPES Provider FirstName | MICHAEL | |
| NPPES Provider ZIPCode | 958165125 | |
| NPPES Provider State | CA | |
| Specialty Description | Dermatology | |
| Total Claim Count | 257.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 12.0 | |
| Percent Opioid Claims | 4.67 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1558460394 |
| Last Name Of The Provider | TRAUNER |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
|
Dr. Michael J. Fazio, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marla L. McClaren, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Victoria R. Sharon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maxwell A. Fung, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas A. Giustina, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Emanual M. Maverakis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zahra S. Torabian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anabella Pascucci, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Larissa N. Larsen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raja K. Sivamani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fu-Tong Liu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shurong Chang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lia C. Keller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vivian Y. Shi, MD
This Doctor is OpenDoctor Recommended.
|